Wednesday, November 25, 2009, 12:45pm SGT - The Singapore stock market closes in 4 hours and 15 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Acorda Therapeutics, Inc. (ACOR)

At 5:00AM SGT: 24.30 USD  Up 0.04 (0.16%)  
 MORE ON ACOR 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Acorda Therapeutics, Inc. (NGM:ACOR) Delayed quote dataEdit
After Hours: 24.30 Down 0.00 (0.02%) as of 5:15am SGT on 11/25/09
Last Trade:24.30 USD
Trade Time:5:00AM SGT
Change:Up 0.04 (0.16%)
Prev Close:24.26
Open:24.32
Bid:23.57 x 100
Ask:24.94 x 100
1y Target Est:30.00
Day's Range:24.00 - 24.56
52wk Range:14.89 - 29.27
Volume:298,001
Avg Vol (3m):1,105,570
Market Cap:926.32M
P/E (ttm):N/A
EPS (ttm):-2.17
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add ACOR to Portfolio   Download Data

 HEADLINES 
•Acorda Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
Business Wire (Tue 8:00pm)
•Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
Business Wire (Mon, Nov 16)
•Abbott: Brave or Stupid?
at Motley Fool (Sat, Nov 14)
•ACORDA THERAPEUTICS INC Financials
EDGAR Online Financials (Wed, Nov 11)
•Big Pharma & Biotech
Zacks.com (Tue, Nov 10)
•Big Pharma and Biotech
Zacks.com (Tue, Nov 10)
•ACORDA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Nov 7)
•Zacks Bull and Bear of the Day Highlights: Acorda Therapeutics, Canon, Big Lots, Wal-Mart and Nordstrom
Zacks.com (Fri, Nov 6)
•Acorda Therapeutics (ACOR)
Zacks.com (Fri, Nov 6)
•New Star Analyst Rankings for Acorda Therapeutics, Inc.
StarMine (Wed, Nov 4)
•A Little Distracted, Are You, Merck?
at Motley Fool (Wed, Nov 4)
•Acorda Therapeutics 3Q loss widens on costs
AP (Wed, Nov 4)
•Acorda Therapeutics Earnings Call scheduled for 8:30 am ET today
CCBN (Tue, Nov 3)
•Q3 2009 Acorda Therapeutics Earnings Release - Before Market Open
CCBN (Tue, Nov 3)
More Headlines for ACOR...
 ANALYST 
EPS Est (next year) (Dec-09) :-2.22
EPS Est (in 2 years) (Dec-10) :-1.68
Avg Rec (current)*:1.9
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Acorda Therapeutics, Inc., a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple sclerosis (MS), spinal cord injury...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices